Condition Lookup
Sub-Category:
Pulmonary Edema
Number of Conditions: 2
Cardiogenic Pulmonary Edema
Specialty: Pulmonology
Category: Pulmonary Vascular Diseases
Sub-category: Pulmonary Edema
Symptoms:
shortness of breath (dyspnea); orthopnea (difficulty breathing while lying flat); paroxysmal nocturnal dyspnea (shortness of breath at night); coughing with frothy pink sputum; rapid breathing (tachypnea); sweating; fatigue and weakness; cyanosis (bluish discoloration of lips or extremities)
Root Cause:
The heart's inability to pump blood effectively leads to increased pressure in the blood vessels of the lungs, causing fluid to leak into the alveoli, resulting in pulmonary edema. This often occurs due to conditions like heart failure, myocardial infarction, or valvular heart disease.
How it's Diagnosed: videos
Physical examination (listening for crackles in the lungs, assessing for signs of heart failure). Chest X-ray (shows signs of pulmonary edema). Echocardiogram (to assess heart function). BNP (B-type natriuretic peptide) test (elevated in heart failure). Arterial blood gas (ABG) test (to assess oxygen levels). Pulmonary artery catheterization (in severe cases).
Treatment:
Oxygen therapy to improve oxygen levels in the blood. Diuretics (e.g., furosemide) to reduce fluid overload. Inotropes (e.g., dobutamine) to improve heart function. Vasodilators (e.g., nitroglycerin) to reduce preload and afterload on the heart. Mechanical ventilation or non-invasive positive pressure ventilation (if severe). Treatment of underlying cause (e.g., coronary artery bypass, valve repair, or treatment for heart failure).
Medications:
Diuretics (e.g., furosemide ) to reduce fluid retention and pulmonary edema. Inotropes (e.g., dobutamine ) to improve heart function in cases of heart failure. Vasodilators (e.g., nitroglycerin ) to relieve heart stress by dilating blood vessels. ACE inhibitors or ARBs to manage underlying hypertension or heart failure.
Prevalence:
How common the health condition is within a specific population.
Cardiogenic pulmonary edema is common in individuals with chronic heart failure, acute myocardial infarction, or valvular diseases. It is responsible for a significant portion of hospital admissions for acute heart failure.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
History of heart disease (e.g., coronary artery disease, heart failure). Hypertension. Valvular heart disease (e.g., aortic or mitral valve stenosis or regurgitation). Arrhythmias (e.g., atrial fibrillation). Myocardial infarction (heart attack). Obesity. Diabetes. Smoking.
Prognosis:
The expected outcome or course of the condition over time.
The prognosis depends on the severity of the heart failure, the underlying cause, and the timeliness of treatment. With appropriate treatment, many individuals can recover, but some may experience chronic heart failure or recurring episodes of pulmonary edema.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure. Cardiogenic shock. Renal failure due to poor perfusion. Arrhythmias. Recurrent episodes of pulmonary edema. Long-term heart failure.
Non-Cardiogenic Pulmonary Edema
Specialty: Pulmonology
Category: Pulmonary Vascular Diseases
Sub-category: Pulmonary Edema
Symptoms:
shortness of breath (dyspnea); tachypnea (rapid breathing); hypoxia (low oxygen levels); cyanosis (bluish lips and extremities); crackles heard on lung auscultation; coughing, often without sputum; fatigue and weakness
Root Cause:
Non-cardiogenic pulmonary edema occurs due to damage to the capillary endothelium, causing increased permeability of the pulmonary capillaries. This allows fluid to leak into the alveoli without heart failure involvement. Common causes include acute respiratory distress syndrome (ARDS), inhalation injuries, infections, or trauma.
How it's Diagnosed: videos
Chest X-ray (often showing diffuse bilateral infiltrates). Arterial blood gas (ABG) to assess oxygenation. Echocardiogram (to rule out cardiac causes). Pulmonary function tests (to assess lung injury). Clinical history (trauma, infection, or other systemic causes)
Treatment:
Oxygen therapy to support breathing and oxygenation. Mechanical ventilation or non-invasive positive pressure ventilation. Treating the underlying cause (e.g., antibiotics for infections, corticosteroids for inflammation). Diuretics (if fluid overload is present). Supportive care (nutritional support, fluid management).
Medications:
Corticosteroids (e.g., methylprednisolone ) may be used to reduce lung inflammation, particularly in ARDS. Antibiotics (e.g., ceftriaxone ) for infections like pneumonia that contribute to non-cardiogenic pulmonary edema. Diuretics (e.g., furosemide ) if fluid overload is present, although not typically used in non-cardiogenic pulmonary edema unless fluid retention is significant.
Prevalence:
How common the health condition is within a specific population.
Non-cardiogenic pulmonary edema is less common than cardiogenic pulmonary edema but is associated with conditions like ARDS and severe trauma, which can occur in various clinical settings.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Acute respiratory distress syndrome (ARDS). Trauma (e.g., head injury, chest trauma, burns). Inhalation of toxic substances (e.g., smoke, chemicals). Severe infections (e.g., pneumonia, sepsis). Acute pancreatitis. Near-drowning. Aspiration of gastric contents.
Prognosis:
The expected outcome or course of the condition over time.
Prognosis is often dependent on the underlying cause. In cases related to ARDS or trauma, outcomes can vary greatly, with some individuals recovering with minimal long-term effects, while others may experience persistent respiratory issues.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure. Long-term lung damage or fibrosis. Persistent hypoxia. Organ failure due to severe systemic inflammation or infection. Chronic respiratory issues (e.g., pulmonary fibrosis).